• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    50 Stocks Moving In Tuesday's Mid-Day Session

    2/22/22 1:54:36 PM ET
    $AIP
    $ALLR
    $ALPN
    $AMLX
    Semiconductors
    Technology
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AIP alert in real time by email

    Gainers

    • Indonesia Energy Corporation Limited (NYSE:INDO) jumped 75.2% to $7.87.
    • Imperial Petroleum Inc. (NASDAQ:IMPP) rose 52.9% to $0.7500 after declining around 7% on Friday.
    • Meritor, Inc. (NYSE:MTOR) shares jumped 45.1% to $35.78. Cummins Inc (NYSE:CMI) agreed to acquire electric powertrain solutions provider Meritor for about $3.7 billion, including assumed debt and net of acquired cash.
    • Ocugen, Inc. (NASDAQ:OCGN) rose 28.3% to $4.44. The FDA has lifted its clinical hold on Ocugen’s investigational new drug application seeking approval to conduct testing of the COVID-19 vaccine Covaxin in the U.S.
    • Riley Exploration Permian, Inc. (NYSE:REPX) gained 19.4% to $28.99 after Truist Securities maintained a Buy rating on the stock and raised its price target from $50 to $55.
    • Arteris, Inc. (NASDAQ:AIP) jumped 17.9% to $17.67. Arteris is expected release its financial results for the fourth quarter on Thursday, March 3, 2022.
    • Houghton Mifflin Harcourt Company (NASDAQ:HMHC) gained 15% to $20.84 after the company announced it will be acquired by Veritas Capital.
    • IronNet, Inc. (NASDAQ:IRNT) gained 15.2% to $4.25.
    • Esperion Therapeutics, Inc. (NASDAQ:ESPR) surged 13.8% to $4.3701 after the company reported better-than-expected Q4 EPS and sales results.
    • 89bio, Inc. (NASDAQ:ETNB) jumped 13.2% to $4.81.
    • Nuvectis Pharma, Inc. (NASDAQ:NVCT) gained 13% to $6.62 as the company disclosed positive data for NXP900 in Triple Negative Breast Cancer preclinical models with an Integrin-Linked Kinase loss.
    • Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) jumped 12.8% to $29.88.
    • Privia Health Group, Inc. (NASDAQ:PRVA) gained 12.7% to $25.18 after Cowen & Co. upgraded the stock from Market Perform to Outperform and announced a $35 price target.
    • IMARA Inc. (NASDAQ:IMRA) rose 8.4% to $1.55 after jumping 16% on Friday. IMARA’s Director David Mott recently acquired a total of 45,926 shares at an average price of $1.19.
    • Digital World Acquisition Corp. (NASDAQ:DWAC) rose 8.2% to $91.19 after Trump's new social media app Truth Social launched on Apple’s App Store on Sunday. Digital World Acquisition is the SPAC partner of former President Donald Trump’s social media startup.
    • BRC Inc. (NYSE:BRCC) rose 7.7% to $20.23 after gaining around 4% on Friday.
    • Healthcare Capital Corp. (NASDAQ:HCCC) shares rose 7.1% to $10.80.


    Check out this: Snap And 4 Other Stocks Sold By Insiders

    Losers

    • Dogness (International) Corporation (NASDAQ:DOGZ) fell 40.1% to $2.56 after the company reported entry into agreement for registered direct offering of approximately $5.66 million of class A common shares.
    • Zosano Pharma Corporation (NASDAQ:ZSAN) shares fell 35.5% to $0.1392. Zosano Pharma recently announced pricing of a $15.4 million public offering of common stock and warrants.
    • Homology Medicines, Inc. (NASDAQ:FIXX) fell 31.2% to $2.6550. The FDA placed a clinical hold on Homology Medicines’ pheNIX gene therapy trial of HMI-102 from the FDA. An official clinical hold letter is expected within 30 days.
    • Allarity Therapeutics, Inc. (NASDAQ:ALLR) shares dipped 30.6% to $4.5754. The FDA provided Allarity Therapeutics with a Refusal to File (RTF) letter for a marketing application for dovitinib for the third-line treatment of metastatic renal cell carcinoma (mRCC).
    • Karyopharm Therapeutics Inc. (NASDAQ:KPTI) fell 29.6% to $10.12 after the company announced changes to its clinical leadership team.
    • FAT Brands Inc. (NASDAQ:FAT) dipped 25.8% to $7.82 after the company said it would be reporting in its 10-K that the SEC has opened investigations relating to the company and CEO Andrew Wiederhorn.
    • Inspirato Incorporated (NASDAQ:ISPO) fell 24.4% to $34.79 after dipping 50% on Friday.
    • Belpointe PREP, LLC (NYSE:OZ) declined 22.3% to $72.98.
    • Sidus Space, Inc. (NASDAQ:SIDU) dropped 22.3% to $5.12.
    • Focus Universal Inc. (NASDAQ:FCUV) dipped 21.6% to $9.23.
    • Tempur Sealy International, Inc. (NYSE:TPX) fell 20% to $29.93 after the company reported worse-than-expected Q4 EPS and sales results.
    • Maris-Tech Ltd. (NASDAQ:MTEK) dipped 19.7% to $1.8207.
    • Kidpik Corp. (NASDAQ:PIK) fell 19.6% to $3.1006.
    • Alpine Immune Sciences, Inc. (NASDAQ:ALPN) dropped 18.5% to $6.09.
    • Cian PLC (NYSE:CIAN) dropped 17.8% to $6.46.
    • Quanergy Systems, Inc. (NYSE:QNGY) shares fell 16.9% to $3.1010 after tumbling 11% on Friday.
    • G Medical Innovations Holdings Ltd (NASDAQ:GMVD) fell 16.7% to $2.2403.
    • Cepton, Inc. (NASDAQ:CPTN) dropped 16.2% to $15.09 mid a continued selloff following last week's surge.
    • Mechel PAO (NYSE:MTL) shares fell 15.1% to $3.0650 after declining around 8% on Friday/
    • Team, Inc. (NYSE:TISI) fell 14.3% to $0.8745 after dipping 12% on Friday. Team recently revealed a series of transactions in its effort to refinance capital structure.
    • Communications Systems, Inc. (NASDAQ:JCS) dropped 14.2% to $2.17.
    • Anghami Inc. (NASDAQ:ANGH) shares fell 14.2% to $14.02 after dipping 43% on Friday.
    • RLX Technology Inc. (NYSE:RLX) dropped 14.2% to $2.9850.
    • Markforged Holding Corporation (NYSE:MKFG) dipped 12.5% to $3.9880.
    • Twin Vee Powercats Co. (NASDAQ:VEEE) dropped 12% to $3.09.
    • Yandex N.V. (NASDAQ:YNDX) fell 11% to $39.81. Yandex recently reported fourth-quarter FY21 revenue growth of 54% year-on-year to $1.485 billion.
    • Ozon Holdings PLC (NASDAQ:OZON) fell 9.8% to $17.10 after declining 8% on Friday.
    • Meten Holding Group Ltd. (NASDAQ:METX) shares fell 9.4% to $0.1850.
    • Creative Realities, Inc. (NASDAQ:CREX) fell 7.8% to $1.07. Creative Realities recently finalized merger with Reflect Systems.
    • LiveOne, Inc. (NASDAQ:LVO) fell 7% to $0.8358. LiveOne’s CEO and Chairman Robert S Ellin recently acquired a total of 25,000 shares at an average price of $0.94.
    • QIWI plc (NASDAQ:QIWI) fell 6.6% to $6.76.
    • Modular Medical, Inc. (NASDAQ:MODD) shares fell 6.3% to $2.82. Modular Medical recently reported pricing of $15 million public offering and uplisting to the Nasdaq Capital Market.
    • Tesla, Inc. (NASDAQ:TSLA) dropped 5.5% to $809.57 from pressure in the overall market as investors weighed the potential economic impacts from rising Russia-Ukraine tensions. Tesla, meanwhile, continues to add numerous Supercharger locations across the country.

    Also check this out: Insiders Buy More Than $170M Of 4 Stocks.

    Get the next $AIP alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AIP
    $ALLR
    $ALPN
    $AMLX

    CompanyDatePrice TargetRatingAnalyst
    Karyopharm Therapeutics Inc.
    $KPTI
    2/5/2026Overweight
    Cantor Fitzgerald
    Tesla Inc.
    $TSLA
    1/30/2026$150.00 → $145.00Underweight
    Analyst
    Cummins Inc.
    $CMI
    1/26/2026Outperform → Peer Perform
    Wolfe Research
    Tesla Inc.
    $TSLA
    1/12/2026$120.00 → $130.00Underweight
    Wells Fargo
    Privia Health Group Inc.
    $PRVA
    1/9/2026$31.00Outperform
    RBC Capital Mkts
    Tesla Inc.
    $TSLA
    1/2/2026$444.00 → $439.00Hold
    Truist
    Cummins Inc.
    $CMI
    12/22/2025$585.00Mkt Perform → Outperform
    Raymond James
    Cummins Inc.
    $CMI
    12/19/2025$546.00Equal Weight → Overweight
    Barclays
    More analyst ratings

    $AIP
    $ALLR
    $ALPN
    $AMLX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Bluescape Riley Exploration Holdings Llc sold $9,086,839 worth of shares (317,944 units at $28.58) (SEC Form 4)

    4 - Riley Exploration Permian, Inc. (0001001614) (Issuer)

    2/10/26 4:12:42 PM ET
    $REPX
    Oil & Gas Production
    Energy

    New insider Hill Gary L. claimed no ownership of stock in the company (SEC Form 3)

    3 - TEAM INC (0000318833) (Issuer)

    2/10/26 12:48:02 PM ET
    $TISI
    Other Consumer Services
    Consumer Discretionary

    President and CEO Paulson Richard A. was granted 81,060 shares, increasing direct ownership by 41% to 279,391 units (SEC Form 4)

    4 - Karyopharm Therapeutics Inc. (0001503802) (Issuer)

    2/9/26 4:11:58 PM ET
    $KPTI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AIP
    $ALLR
    $ALPN
    $AMLX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Cummins Inc. Declares Quarterly Common Stock Dividend

    The Board of Directors of Cummins Inc. (NYSE:CMI) today declared a quarterly common stock cash dividend of 2.00 dollars per share. The dividend is payable on March 5, 2026, to shareholders of record on February 20, 2026. About Cummins Inc. Cummins Inc., a global power leader, is committed to powering a more prosperous world. Since 1919, we have delivered innovative solutions that move people, goods and economies forward. Our five business segments—Engine, Components, Distribution, Power Systems and Accelera™ by Cummins—offer a broad portfolio, including advanced diesel, electric and hybrid powertrains; integrated power generation systems; critical components such as aftertreatment, turb

    2/10/26 4:15:00 PM ET
    $CMI
    Industrial Machinery/Components
    Industrials

    Sidus Space and Simera Sense sign Memorandum of Understanding (MOU) to Advance AI‑Enabled Hyperspectral Imaging for Near Real‑Time Earth Observation

    Collaboration focuses on integrating advanced hyperspectral imaging with onboard data processing capabilities to enable faster, smarter insights from orbit. CAPE CANAVERAL, Fla., Feb. 10, 2026 /PRNewswire/ -- Sidus Space, Inc. (NASDAQ:SIDU), an innovative space and defense technology company, today announced the signing of a Memorandum of Understanding (MOU) with Simera Sense, a leading provider of optical payloads and data analytics for satellite Earth observation. The agreement outlines a strategic collaboration to support the development of next‑generation hyperspectral imaging solutions incorporating onboard data processing and analytics, with the goal of enabling commercially deployable

    2/10/26 8:30:00 AM ET
    $SIDU
    Telecommunications Equipment
    Telecommunications

    Imperial Petroleum Announces $10 Million Share Repurchase Program

    ATHENS, Greece, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Imperial Petroleum Inc. (NASDAQ:IMPP) (the "Company") today announced that its Board of Directors has approved a share repurchase program and authorized the officers of the Company to repurchase, from time to time, up to $10,000,000 of the Company's common stock. Shares may be purchased in open market or privately negotiated transactions, at times and prices that are considered to be appropriate by the Company, and the program may be suspended or discontinued at any time. About Imperial Petroleum Inc. IMPERIAL PETROLEUM INC. is a ship-owning company providing petroleum products, crude oil and drybulk seaborne transportation services. The

    2/9/26 9:20:00 AM ET
    $IMPP
    Marine Transportation
    Consumer Discretionary

    $AIP
    $ALLR
    $ALPN
    $AMLX
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for NEXLIZET issued to ESPERION THERAPS INC

    Submission status for ESPERION THERAPS INC's drug NEXLIZET (SUPPL-16) with active ingredient BEMPEDOIC ACID; EZETIMIBE has changed to 'Approval' on 03/22/2024. Application Category: NDA, Application Number: 211617, Application Classification: Efficacy

    3/25/24 4:41:30 AM ET
    $ESPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for NEXLIZET issued to ESPERION THERAPS INC

    Submission status for ESPERION THERAPS INC's drug NEXLIZET (SUPPL-17) with active ingredient BEMPEDOIC ACID; EZETIMIBE has changed to 'Approval' on 03/22/2024. Application Category: NDA, Application Number: 211617, Application Classification: Efficacy

    3/25/24 4:41:37 AM ET
    $ESPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for NEXLETOL issued to ESPERION THERAPS INC

    Submission status for ESPERION THERAPS INC's drug NEXLETOL (SUPPL-13) with active ingredient BEMPEDOIC ACID has changed to 'Approval' on 03/22/2024. Application Category: NDA, Application Number: 211616, Application Classification: Efficacy

    3/25/24 4:41:29 AM ET
    $ESPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AIP
    $ALLR
    $ALPN
    $AMLX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Firestone Karen bought $100,845 worth of shares (8,100 units at $12.45), increasing direct ownership by 15% to 63,100 units (SEC Form 4)

    4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)

    12/23/25 8:48:33 PM ET
    $AMLX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Large owner Corre Partners Management, Llc bought $44,675 worth of shares (2,996 units at $14.91) (SEC Form 4)

    4 - TEAM INC (0000318833) (Issuer)

    12/8/25 7:31:50 PM ET
    $TISI
    Other Consumer Services
    Consumer Discretionary

    Large owner Corre Partners Management, Llc bought $208,166 worth of shares (14,034 units at $14.83) (SEC Form 4)

    4 - TEAM INC (0000318833) (Issuer)

    12/3/25 8:57:42 PM ET
    $TISI
    Other Consumer Services
    Consumer Discretionary

    $AIP
    $ALLR
    $ALPN
    $AMLX
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13D/A filed by Riley Exploration Permian Inc.

    SCHEDULE 13D/A - Riley Exploration Permian, Inc. (0001001614) (Subject)

    2/10/26 6:08:15 PM ET
    $REPX
    Oil & Gas Production
    Energy

    SEC Form SCHEDULE 13G filed by Karyopharm Therapeutics Inc.

    SCHEDULE 13G - Karyopharm Therapeutics Inc. (0001503802) (Subject)

    2/10/26 4:48:45 PM ET
    $KPTI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 10-K filed by Cummins Inc.

    10-K - CUMMINS INC (0000026172) (Filer)

    2/10/26 3:11:40 PM ET
    $CMI
    Industrial Machinery/Components
    Industrials

    $AIP
    $ALLR
    $ALPN
    $AMLX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Cantor Fitzgerald initiated coverage on Karyopharm Therapeutics

    Cantor Fitzgerald initiated coverage of Karyopharm Therapeutics with a rating of Overweight

    2/5/26 6:58:02 AM ET
    $KPTI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Analyst reiterated coverage on Tesla with a new price target

    Analyst reiterated coverage of Tesla with a rating of Underweight and set a new price target of $145.00 from $150.00 previously

    1/30/26 8:00:23 AM ET
    $TSLA
    Auto Manufacturing
    Industrials

    Cummins downgraded by Wolfe Research

    Wolfe Research downgraded Cummins from Outperform to Peer Perform

    1/26/26 10:01:23 AM ET
    $CMI
    Industrial Machinery/Components
    Industrials

    $AIP
    $ALLR
    $ALPN
    $AMLX
    Leadership Updates

    Live Leadership Updates

    View All

    Ocugen Appoints Rita Johnson-Greene to Chief Financial Officer

    MALVERN, Pa., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ:OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced the appointment of Rita Johnson-Greene as Chief Financial Officer (CFO). "Mrs. Johnson-Greene's diverse background across a variety of strategic roles at organizations representing many facets of the industry make her well-suited to serve as Ocugen's CFO," said Dr. Shankar Musunuri, Chairman, CEO, and Co-founder of Ocugen. "We look forward to her leadership as we enter into a transformative time at Ocugen, beginning with the submission of the first of three Biologics License Applications (BLAs) this

    2/9/26 7:02:00 AM ET
    $OCGN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Team, Inc. Announces Planned Leadership Transition and Names Gary Hill as Chief Executive Officer

    SUGAR LAND, Texas, Jan. 26, 2026 (GLOBE NEWSWIRE) -- Team, Inc. (NYSE:TISI) ("TEAM" or the "Company"), a leading provider of specialty industrial services offering a full suite of mechanical, heat-treating, and inspection services around the world, today announced that Keith Tucker will retire from Team after over 20 years of service. In conjunction with this planned leadership transition, TEAM's Board of Directors has appointed Gary Hill as the Company's Chief Executive Officer effective February 1, 2026 to lead the Company in its continued focus on driving accelerated growth and margin improvements. The Company also reaffirms its previously issued 2025 outlook. "On behalf of the Board o

    1/26/26 5:00:00 PM ET
    $TISI
    Other Consumer Services
    Consumer Discretionary

    Melissa Xides Appointed Exclusive Resorts President

    Former Bergdorf Goodman executive joins to strengthen a more private, relationship-led Club for a discerning global Membership Exclusive Resorts today announced the appointment of Melissa Xides as President, signaling a new chapter for the Members-only luxury club following a sustained period of growth and the recent launch of The Exclusive Collective, uniting three market-leading brands to form one of the most expansive private networks in luxury hospitality. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260113869302/en/Melissa Xides, President - Exclusive Resorts After more than six years of expansion across the Club's $1 b

    1/13/26 8:00:00 AM ET
    $ISPO
    Blank Checks
    Finance

    $AIP
    $ALLR
    $ALPN
    $AMLX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Maris-Tech Ltd.

    SC 13G/A - Maris Tech Ltd. (0001872964) (Subject)

    12/13/24 11:34:57 AM ET
    $MTEK
    Telecommunications Equipment
    Telecommunications

    Amendment: SEC Form SC 13D/A filed by Twin Vee PowerCats Co.

    SC 13D/A - Twin Vee PowerCats, Co. (0001855509) (Subject)

    11/27/24 4:15:33 PM ET
    $VEEE
    Marine Transportation
    Industrials

    Amendment: SEC Form SC 13G/A filed by Maris-Tech Ltd.

    SC 13G/A - Maris Tech Ltd. (0001872964) (Subject)

    11/27/24 10:44:51 AM ET
    $MTEK
    Telecommunications Equipment
    Telecommunications

    $AIP
    $ALLR
    $ALPN
    $AMLX
    Financials

    Live finance-specific insights

    View All

    Cummins Inc. Declares Quarterly Common Stock Dividend

    The Board of Directors of Cummins Inc. (NYSE:CMI) today declared a quarterly common stock cash dividend of 2.00 dollars per share. The dividend is payable on March 5, 2026, to shareholders of record on February 20, 2026. About Cummins Inc. Cummins Inc., a global power leader, is committed to powering a more prosperous world. Since 1919, we have delivered innovative solutions that move people, goods and economies forward. Our five business segments—Engine, Components, Distribution, Power Systems and Accelera™ by Cummins—offer a broad portfolio, including advanced diesel, electric and hybrid powertrains; integrated power generation systems; critical components such as aftertreatment, turb

    2/10/26 4:15:00 PM ET
    $CMI
    Industrial Machinery/Components
    Industrials

    LiveOne (Nasdaq: LVO) Expects $57.9M+ Fiscal 2026 YTD Revenue, $19.9M+ Q3 Fiscal 2026 Revenue, $1.0M+ Q3 Fiscal 2026 Adjusted EBITDA*, up ~200% QoQ

    B2B partnerships across Amazon, YouTube, Spotify, Apple, Paramount, YouTube, DAX, TextNow, Telly and AI partners Listener.com and Intuizi continue to drive growth Anticipates launching three Fortune 500 partnerships by year-end across carrier, retail, and TV100+ potential partnerships in the pipelineAchieves 52% YoY OpEx reduction; targeting a 34% YoY headcount reduction ($4M - $5M in savings) by year-end through AI-driven cost optimizationPaid off $2.5M of debt LOS ANGELES, Feb. 05, 2026 (GLOBE NEWSWIRE) -- LiveOne (NASDAQ:LVO), an award-winning, creator-first music, entertainment, and technology platform, announced today certain anticipated financial results for its third fiscal quarter

    2/5/26 8:00:00 AM ET
    $LVO
    Restaurants
    Consumer Discretionary

    Karyopharm to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026

    -- Conference Call Scheduled for Thursday, February 12, 2026, at 8:00 a.m. ET -- NEWTON, Mass., Feb. 5, 2026 /PRNewswire/ -- Karyopharm Therapeutics Inc. (NASDAQ:KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced it will report fourth quarter and full year 2025 financial results on Thursday, February 12, 2026. Karyopharm's management team will host a conference call and audio webcast at 8:00 a.m. ET on Thursday, February 12, 2026, to discuss the financial results and other company updates. To access the conference call, please dial (800) 836-8184 (local) or (646) 357-8785 (international) at least 10 minutes prior to the start time and ask to b

    2/5/26 7:30:00 AM ET
    $KPTI
    Biotechnology: Pharmaceutical Preparations
    Health Care